Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Seagen Inc (NQ: SGEN ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Seagen Inc < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside. November 06, 2023 The company was expected to report a third-quarter loss and plummeting sales. Via Investor's Business Daily This Is The 'Only Solar Stock' Jim Cramer Is Recommending 'Because It's A Pure Play' November 06, 2023 On CNBC’s "Mad Money Lightning Round," Jim Cramer said DocuSign, Inc. Via Benzinga CPRI, SGEN, VMW: Why These 3 Stocks Are on the Tip of Bill Gross’ Tongue November 05, 2023 Bill Gross, the Bond King, is wading into the world of equity arbitrage with these three stocks - but are they worth the risk for investors? Via InvestorPlace Here's How Much You Would Have Made Owning Seagen Stock In The Last 15 Years November 03, 2023 Via Benzinga Seagen Highlights First Solid Tumor Data for an ADCETRIS® (brentuximab vedotin) Immunotherapy Combination and Preclinical Data for Novel CD30-Directed Antibody-Drug Conjugate at Society for Immunotherapy of Cancer (SITC) Annual Meeting November 03, 2023 From Seagen Inc. Via Business Wire This High-Yield Dividend Stock Is a Proven Wealth Creator November 02, 2023 This heavily sold-off pharma stock is a bargain. Via The Motley Fool Looking At Seagen's Recent Unusual Options Activity November 01, 2023 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session November 02, 2023 Via Benzinga New Data for ADCETRIS® (brentuximab vedotin) with Immunotherapy Combination in Hodgkin Lymphoma to be Featured at 2023 ASH Annual Meeting, and Seagen to Unveil Novel CD30-Directed Antibody-Drug Conjugate November 02, 2023 From Seagen Inc. Via Business Wire Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress November 01, 2023 From Seagen Inc. Via Business Wire The 7 Most Undervalued Long-Term Stocks to Buy: October 2023 October 29, 2023 Equities remain under pressure, but if you’re looking to be a contrarian investor, it’s a good time to look for undervalued long-term stocks. Via InvestorPlace (SGEN) - Analyzing Seagen's Short Interest October 23, 2023 Via Benzinga Seagen Inc. (NASDAQ: SGEN) Climbs to New 52-Week High October 23, 2023 Via Investor Brand Network Earnings Scheduled For November 1, 2023 November 01, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. Via Benzinga Earnings Outlook For Seagen October 31, 2023 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session October 25, 2023 Via Benzinga Seagen Inc. (NASDAQ: SGEN) Sets New 52-Week High in Tuesday Session October 24, 2023 Via Investor Brand Network How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks October 22, 2023 The companies studied a combination of Keytruda and Padcev in bladder cancer patients. Via Investor's Business Daily Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer October 22, 2023 From Seagen Inc. Via Business Wire Here's How Much $1000 Invested In Seagen 5 Years Ago Would Be Worth Today October 17, 2023 Via Benzinga How Is The Market Feeling About Seagen? October 06, 2023 Via Benzinga TIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared with Chemotherapy in Global Phase 3 innovaTV 301 Trial October 22, 2023 From Seagen Inc. Via Business Wire Which Is the Better Long-Term Hold for Investors: Pfizer or Roche? October 21, 2023 The venerable pharmaceutical companies' shares have slumped this year. Via The Motley Fool Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research October 20, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety Seagen to Highlight Overall Survival Data for PADCEV® and TIVDAK® during Presidential Symposium at ESMO Congress 2023 October 16, 2023 From Seagen Inc. Via Business Wire Seagen to Report Third Quarter 2023 Financial Results on November 1, 2023 October 12, 2023 From Seagen Inc. Via Business Wire Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment October 11, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END Via FinancialNewsMedia 10 Health Care Stocks Whale Activity In Today's Session October 09, 2023 Via Benzinga Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study October 05, 2023 Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one of its dual primary endpoints of disease-free survival for the adjuvant... Via Benzinga 2 High-Yield Dividend Stocks to Buy in October October 04, 2023 These two high-yield dividend stocks are too cheap to ignore. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.